Suppr超能文献

一项利用沙门氏菌/微粒体试验对某些保加利亚药物致突变作用的研究。

A study on the mutagenic effect of some Bulgarian drugs using the Salmonella/microsome test.

作者信息

Dimitrova K, Ivanov V, Bogoeva M, Golovinsky E, Markov K

出版信息

Acta Physiol Pharmacol Bulg. 1983;9(4):31-6.

PMID:6375259
Abstract

It has been shown that mixtures of phenobarbital and 3- methylcholantrene may be used in the Salmonella/microsome test as inductors of the S9 liver fraction, instead of "Aroclor 1254". The Salmonella/microsome method has been used to study the mutagenic action of Flatogel (2.5% polymethylsyloxanum activatum and 2% ethylium -p- aminobenzoicum , suspended in sorbitol-balanced gel of aluminum hydroxidatum and magnesium hydroxidatum ), Nitrolong (2,2-bis/hydroxymethyl/-1,3- propandioltetranitrate ) and Cymethidine (N-cyano-N'-methyl-N"/2-/5-methyl-4-imidazolyl-methylthio/ethyl/guanidin e). These substances are produced as drugs by the Bulgarian chemical and pharmaceutical industry ( PHARMACHIM ). The results obtained show that the drugs studied have no mutagenic action, both without and with activation with S9 liver fraction isolated from rats treated with "Aroclor 1254" or combinations of phenobarbital and 3- methylcholantrene .

摘要

已表明,苯巴比妥和3-甲基胆蒽的混合物可在沙门氏菌/微粒体试验中用作S9肝组分的诱导剂,以替代“Aroclor 1254”。沙门氏菌/微粒体方法已用于研究弗拉托凝胶(2.5%活性聚甲基硅氧烷和2%对氨基苯甲酸乙酯,悬浮于氢氧化铝和氢氧化镁的山梨醇平衡凝胶中)、硝酸甘油(2,2-双/羟甲基/-1,3-丙二醇四硝酸酯)和西咪替丁(N-氰基-N'-甲基-N''/2-(5-甲基-4-咪唑基-甲基硫代)乙基/胍)的诱变作用。这些物质由保加利亚化学和制药工业(PHARMACHIM)作为药物生产。所得结果表明,所研究的药物无论在不使用从用“Aroclor 1254”或苯巴比妥与3-甲基胆蒽组合处理的大鼠分离的S9肝组分激活的情况下,还是在有该激活的情况下,均无诱变作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验